Carlos M. Martínez‐Viturro

Author

Also Known As

Carlos M. Martinez‐Viturro, Carlos M. Martínez-Viturro, Carlos M. Martínez‐Viturro, Carlos Manuel Martínez-Viturro, M.L. Martin

Publications

233

Citations

H-Index

Concepts

All Affiliations

Janssen (Belgium)Universidade de Santiago de Compostela

About

Carlos M. Martínez‐Viturro is an author at Janssen (Belgium) specializing in drug discovery, medicinal chemistry, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	174
2	Social Sciences	3	3	115
3	Neuroscience	3	3	115
4	Biochemistry	1	1	43
5	Molecular Biology	1	1	52

Carlos M. Martínez‐Viturro

Publications

195

Citations

H-Index

Page 1

	Year	Citations
Discovery of VU0409551/JNJ-46778212: An mGlu<sub>5</sub> Positive Allosteric Modulator Clinical Candidate Targeting Schizophrenia Susana Conde-Ceide, Carlos M. Martínez‐Viturro, Jesús Alcázar, ACS Medicinal Chemistry Letters Psychotropic MedicationMolecular BiologyPsychopharmacologyPharmacotherapySocial Sciences	2015	52
Discovery of a Potent, Selective, and Orally Active Phosphodiesterase 10A Inhibitor for the Potential Treatment of Schizophrenia José Manuel Bartolomé-Nebreda, Francisca Delgado, Maria Luz Martı́n-Martı́n, Journal of Medicinal Chemistry PsychopharmacologyPharmacotherapySocial SciencesMedicinal ChemistryInhibitory Activity	2014	43
Synthesis of the antitumoural agent batracylin and related isoindolo[1,2-b]quinazolin-12(10H)-ones Carlos M. Martínez‐Viturro, Domingo Domı́nguez Tetrahedron Letters Antitumoural Agent BatracylinMedicinal ChemistryAntiparasitic AgentMedicineAnti-cancer Agent	2006	38
Synthesis of aza analogues of the anticancer agent batracylin Carlos M. Martínez‐Viturro, Domingo Domı́nguez Tetrahedron Letters Medicinal ChemistryMedicineAza AnaloguesPharmacotherapyAnti-cancer Agent	2007	21
Diazaspirononane Nonsaccharide Inhibitors of O-GlcNAcase (OGA) for the Treatment of Neurodegenerative Disorders Carlos M. Martínez‐Viturro, Andrés A. Trabanco, Jordi Royes, Journal of Medicinal Chemistry	2020	21
Identification of a Novel Orally Bioavailable Phosphodiesterase 10A (PDE10A) Inhibitor with Efficacy in Animal Models of Schizophrenia. José Manuel Bartolomé-Nebreda, Sergio A. Alonso de Diego, Marta Artola, Journal of Medicinal Chemistry PsychopharmacologyPharmacotherapyPharmaceutical ChemistrySocial SciencesMolecular Pharmacology	2014	20

Page 1